Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Improved drug-target deconvolution with PISA-DIA using an extended, overlapping temperature gradient

ABSTRACT: For target-engagement applications, a comparative analysis was performed to assess the suitability, ease of implementation and cost-effectiveness between Cellular Thermal Shift Assay (CETSA) and Proteome Integral Solubility Alteration (PISA). Human multiple myeloma cells U266B1 cell lysate was treated with either 1 μM BCL-XL inhibitor or DMSO as a vehicle to perform i) label-free PISA approach to analyse each PISA pool by data-independent acquisition (DIA) approach (PISA-DIA-MS) and ii) traditional TMT labelled proteome-wide CETSA approach (CETSA-TMT-MS).

INSTRUMENT(S): Orbitrap Eclipse, timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Cell

DISEASE(S): Multiple Myeloma

SUBMITTER: Laura Dagley

LAB HEAD: Dr. Laura Dagley

PROVIDER: PXD044545 | Pride | 2024-05-20

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	2401_ReporterAdj_P4093_FAIMS_2001_CETSA-TMT_RF0141_T1-T4_injection1.msf	Msf
	2401_ReporterAdj_P4093_FAIMS_2001_CETSA-TMT_RF0141_T1-T4_injection2.msf	Msf
	2401_ReporterAdj_P4093_FAIMS_2001_CETSA-TMT_RF0141_T5-T8_injection1.msf	Msf
	2401_ReporterAdj_P4093_FAIMS_2001_CETSA-TMT_RF0141_T5-T8_injection2.msf	Msf
	P4093_10_P2_Control_R1_1_1_6857.d.zip	Other

Items per page:

1 - 5 of 32

Similar Datasets

Multifaceted proteome analysis at solubility, redox, and expression dimensions for target identification

Project description:Multifaceted interrogation of the proteome deepens the system-wide understanding of biological systems; however, mapping the redox changes in the proteome has so far been significantly less informative than expression and solubility/stability analyses. Here, we devise the first high-throughput redox proteomics approach integrated with expression analysis (REX) and combine it with Proteome Integral Solubility Alteration (PISA) assay. The whole PISA-REX experiment in three biological replicates is multiplexed in a single tandem mass tag set (TMTpro). For benchmarking this compact PISA-REX tool, we analyzed HCT116 cells treated with auranofin. Then we applied PISA-REX to study the targets of Pladienolide B in SW620 cells, proteome remodeling upon stimulation of human monocytes by interferon α, and to paired primary and metastatic colon cancer cells. Providing comprehensive multifaceted information on the proteome, the compact PISA-REX has the potential to become an industry-standard in proteomics and to open new windows into the biology of health and disease.

2024-08-10 | PXD042967 | Pride

Chloroquine Target Identification with MS-CETSA

Project description:ITDR MS-CETSA was conducted on chloroquine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.

2023-12-11 | PXD046662 | Pride

Pyronaridine Target Identification with MS-CETSA

Project description:ITDR MS-CETSA was conducted on pyronaridine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.

2023-12-11 | PXD046551 | Pride

Amodiaquine Target Identification with MS-CETSA

Project description:ITDR MS-CETSA was conducted on amodiaquine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.

2023-12-11 | PXD046647 | Pride

MK4815 Target Identification with MS-CETSA

Project description:ITDR MS-CETSA was conducted on MK4815-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.

2023-12-11 | PXD046642 | Pride

MMV665806 Target Identification with MS-CETSA

Project description:ITDR MS-CETSA was conducted on MMV665806-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.

2023-12-11 | PXD046575 | Pride

Piperaquine Target Identification with MS-CETSA

Project description:ITDR MS-CETSA was conducted on piperaquine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.

2023-12-11 | PXD046578 | Pride

MMV000848 Target Identification with MS-CETSA

Project description:ITDR MS-CETSA was conducted on MMV000848-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.

2023-12-11 | PXD046538 | Pride

Lumefantrine Target Identification with MS-CETSA

Project description:ITDR MS-CETSA was conducted on lumefantrine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.

2023-12-11 | PXD046584 | Pride

Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate.

Project description:Caspases are a family of proteins mostly known for their role in the activation of the apoptotic pathway leading to cell death. In the last decade, caspases have been found to fulfil other tasks regulating the cell phenotype independently to cell death. Microglia are the immune cells of the brain responsible for the maintenance of physiological brain functions but can also be involved in disease progression when overactivated. We have previously described non30 apoptotic roles of caspase-3 (CASP3) in the regulation of the inflammatory phenotype of microglial cells or pro-tumoral activation in the context of brain tumors. CASP3 can regulate protein functions by cleavage of their target and therefore could have multiple substrates. So far, identification of CASP3 substrates has been performed mostly in apoptotic conditions where CASP3 activity is highly upregulated and these approaches do not have the capacity to uncover CASP3 substrates at the physiological level. In our study, we aim at discovering highaffinity substrates of CASP3 involved in the normal regulation of the cell. We used an unconventional approach by chemically reducing the basal level activity of CASP3 (by DEVD38 fmk treatment) coupled to a Mass Spectrometry screen (PISA) to identify stabilized, and consequently, non-cleaved proteins in microglia cells. PISA identified several significantly stabilized proteins after DEVD-fmk treatment, including a few already known CASP3substrates which validated our approach. Among them, we focused on the Collectin12 (COLEC12 or CL-P1) transmembrane receptor and uncovered a potential role for CASP3 cleavage of COLEC12 in the regulation of the phagocytic capacity of microglial cells. Taken together, these findings suggest a new way to uncover non-apoptotic high-affinity substrates of CASP3 important for the modulation of microglia cell physiology.

2023-05-10 | PXD032835 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data